Aspen Neuroscience (ASPE) vs MapLight Therapeutics (MPLT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aspen Neuroscience is the larger company by market cap ($361.2 million vs $330.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASPE | MPLT |
|---|---|---|
| Share price | $12.42 | $5.94 |
| Market cap | $361.16M | $330.12M |
| 1-day change | +0.24% | -7.48% |
| YTD return | — | -66.18% |
| 1-year return | — | -57.54% |
| EPS (TTM) | $-4.89 | $-6.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-161.15M |
| 52-week high | $14.90 | $40.43 |
| 52-week low | $11.20 | $5.93 |
| Distance from 52-week high | -16.64% | -85.31% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +340.24% |
| Average volume | 352.42K | 458.71K |
| Shares outstanding | 29.08M | 52.85M |
| Employees | 120 | 133 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aspen Neuroscience
ASPE stock →Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees
About MapLight Therapeutics
MPLT stock →MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 133 employees
ASPE vs MPLT FAQ
Which is bigger, Aspen Neuroscience or MapLight Therapeutics?
Aspen Neuroscience (ASPE) is larger, with a market capitalization of $361.16M compared with $330.12M for MapLight Therapeutics (MPLT).
Are Aspen Neuroscience and MapLight Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.